Welltower Inc. (WELL)

REIT de vivienda para adultos mayores y salud

The largest senior housing REIT in the United States, the United Kingdom and Canada (more than 2,500 properties), with occupancy recovering (85.1%→87.4% in 2025) and solid organic growth (Same-Store NOI in the operated segment +21.0%). But at $230 reported FFO fell due to a real, one-time stock-based compensation charge (a cost the method always expenses, never adds back) and much of the recent growth is inorganic: base 5-year value $123 (-12%/year price, -10% with dividend): Overvalued.

Moat Compounder estimates the intrinsic value of Welltower Inc. (WELL) at $123 per share on a five-year horizon. With the stock at $230.29 at 2026-10-12 close, the expected total return is -9.6% per year: overvalued. The analysis draws on 10-K FY2025 and Quarterly XBRL data (TTM through Mar-31-2026). Analysis dated 2026-07-28.

Price: $230.29
Intrinsic value (5y, base): $123
Total annual return (5y): -9.6%
Status (nominal): Overvalued
Margin of safety: No margin

The essentials

The largest senior housing REIT in the world: more than 2,500 communities in the U.S., the United Kingdom (~20.0% of revenue) and Canada (~6.8%), with 62 operating partners and only 712 direct employees. Three segments: Seniors Housing Operating (~78% of revenue, mostly under the RIDEA structure), Triple-net (~11%) and Outpatient Medical (~7%, being divested).
Recent growth (revenue +40.2% FY25, +43.5% TTM) is mostly inorganic: large acquisitions (Care UK, Barchester, HC-One) and an ongoing ~$7.2bn sale of the Outpatient Medical portfolio. The real organic engine —the one underpinning the valuation— is the segment-weighted Same-Store NOI, of approximately +17% per year.
Reported FY2025 FFO ($1.818bn, -22% vs FY24) fell because of a real $1,409M stock-based compensation charge from the new ten-year executive continuity program — a cost the method always expenses. On that reported FFO, the current price implies an extreme multiple; even taking as a reference the FFO excluding that one-off charge (a reading this analysis does not treat as a valid normalization of the cost, only as the starting point of the projected path), the multiple runs around 52× — on either reading, far above the reference range for a REIT.

Source 10-K FY2025 2025-12-31 ·Quarterly XBRL data (TTM through Mar-31-2026) 2026-03-31 ·DEF 14A 2026 (proxy statement) 2026-04-10

Health: Fragile

Price $230 at 2026-10-12 closeMarket Cap $167.3 bnEnterprise Value $180.5 bnNet debt $13.2 bnP/FFO (today) 51.8x

Intrinsic value — two valuation methods

No margin of safety

Price market

$230

DCF value today

$231

+0.5% vs price

Multiples value today

$116

-49.7% vs price

Total return at 5 years: -9.5%/year = -11.8% appreciation + 2.2% dividend. The target price ($123) is ex-dividend; the $20 in dividends collected over 5 years are added separately.

The methods disagree: one places the value today above the price ($230) and the other below.

Pillars of the analysis

The verdict — today vs 5 years

Today — expensive, no margin of safety: at $230 trades ~98.6% above its value discounted to today (~$116); the expected return does not even reach the risk-free rate (4.5%).

At 5 years — Sobrevalorado: the expected total return is negative — the price already discounts a demanding scenario that, if not met, results in a loss.

The bridge: the return at 5 years falls below the risk-free rate (4.5%) — which is why there is not even a discount to today's value. To require a 15% annual return, it would need to be bought at ~$74.

Thesis

The business

Welltower is the largest senior housing REIT in the world, with a moat resting on scarce licensed locations, a proprietary data platform, a network of 62 operators and a balance sheet capable of funding large-scale acquisitions. Occupancy is recovering strongly (85.1%→87.4% in 2025) and Same-Store NOI in the operated segment is growing +21.0% — the underlying business is of high quality and benefits from a structural demographic tailwind (the silver economy).

The valuation

A REIT is valued on P/FFO, not P/E (real estate depreciation is not an economic cost). Reported FY2025 FFO ($1.818bn, $2.68/share, -22% vs FY24) fell due to a real $1,409M charge for stock-based compensation from the new executive continuity program and the ongoing sale of the Outpatient Medical portfolio. Stock-based compensation is a real cost —the method always expenses it, never adds it back—, so reported FFO is the correct figure: at $230 it implies an extreme entry multiple. This analysis takes as the path's year-0 the FFO excluding that one-time charge (~$3.227bn) only to isolate the business's recurring level, not as a valid normalization of the cost —which was paid regardless, through share dilution—; using that more favorable figure, the entry multiple at $230 is still 52× — under either reading, far above the method's reference range for a REIT (P/FFO 15-20×). The base scenario projects aggregate FFO growing from the weighted organic growth rate (~17%, segment Same-Store NOI) plus already-closed acquisitions, decelerating to ~8% by year 5, with shares diluting from equity funding of acquisitions; the exit multiple compresses to 18× → $123/share, a price CAGR of -12%, -10% with the dividend (1.5%).

The margin of safety

No margin of safety: the price already discounts a demanding scenario. The market price already prices in a continuation of the recent growth pace that is largely inorganic (acquisitions funded with debt and share issuance), on top of reported FFO that also carried a real, one-time stock-based compensation charge —which the method always expenses— and reduced the year's FFO per share. Applying the method's reference range for a REIT (P/FFO 15-20×) to the year-0 FFO used in the path and projected with organic growth, the verdict is Overvalued: the business is high quality, but the price leaves no margin under any reading of FFO.

What to watch

The central disconfirming test: if Same-Store NOI in the operated segment (+21.0% in 2025) sustains that pace beyond the post-pandemic occupancy recovery, real organic growth could exceed this analysis's normalized path and the verdict would be revised upward. In the opposite direction: watch whether the executive compensation charge recurs (the program runs ten years, and only part of it was recognized in 2025), whether the pace of dilution from share issuance keeps funding acquisitions at the same rate, and the impact of the Medicaid reimbursement cut (OBBBA, starting 2028) on operators' ability to pay.

Educational / informational. Does not constitute investment advice.

The valuations

Valuation by multiples

Welltower (FFO × P/FFO) Senior housing and healthcare REIT (Seniors Housing Operating + Triple-net + Outpatient Medical), valued on P/FFO (direct equity; FFO is already after interest)

Core FFO / share at 5 years $6.83

× P/FFO 18.0x

= Target price / share (5 years) $123

The multiple is applied to the metric per share (EPS / Core FFO): that metric already reflects the evolution of the share count (buybacks or issuance), so the share count does not enter as a separate step. The implied equity (~$89.3 bn) is the metric carried to the equivalent of today's share count — the detail is in the piece's (i).

Value today (cash flow discounted at the risk-free rate)

Target price at 5 years $123 · discounted to today at Rf 4.5% $99

+ PV of dividends (5y, year by year) $17

= Value today $116

vs current price $230 -49.7% (value below the price)

Discounted cash flow to present value (DCF)

Year-0 FFO used in the projected path (FY2025), which excludes the one-time $1,409M stock-based compensation charge from the new Ten-Year Executive Continuity and Alignment Program recognized in the 10-K — this is not a valid normalization of the cost (stock-based compensation is always expensed); it is only the path's starting point, since on reported FFO the current entry multiple is even higher (~90×) as the base. Move the assumptions: the value recalculates live. The verdict remains anchored by multiples; the DCF contrasts it at present value.

Discount rate — risk-free (4.5% floor) effective = 4.5%

Risk-free rate 4.5%

Risk does not inflate the rate: protection is required separately, as a margin of safety over the value. The floor avoids discounting at the pace of a depressed market rate.

Base owner earnings $3.2 bn

Growth 20.0%

Terminal g 0.0%

Years 5 years

Year	Projected FCF	Discount factor	Present value
1	$3.9 bn	0.957	$3.7 bn
2	$4.6 bn	0.916	$4.3 bn
3	$5.6 bn	0.876	$4.9 bn
4	$6.7 bn	0.839	$5.6 bn
5	$8 bn	0.802	$6.4 bn

PV of explicit flows (Σ) $24.9 bn

Terminal value = FCF₅₊₁ / (Rf − g) $178.4 bn

PV of terminal value $143.2 bn

= Enterprise value $168.1 bn

+ Net cash $0 bn

= Equity $168.1 bn

÷ 726 M shares

Implied value / share $231

vs current price $230 +0.5% (value above the price)

85% of the DCF value is in the terminal value. Method convention: the terminal is taken with no growth (g = 0) — growth beyond the explicit horizon is not paid for today; what the business achieves afterward is part of the margin, not the price. The perpetuity still dominates and makes the DCF sensitive to the assumptions; that is why the multiples valuation —with an explicit exit multiple— drives the verdict.

Reverse DCF — what growth the price discounts

The inverse approach: instead of projecting growth to obtain the value, the market price ($230) is taken as given and it solves for what annual owner-earnings growth would need to hold for 5 years for the present value —at the method's rate (4.5%, no-growth terminal)— to equal that price. It is the disconfirmation test: the expectations the price already pays for, contrasted against the method's projection.

The price discounts +19.9%/year

Our base case projects +20.0%/year

The implied growth (19.9%/year) is in line with our base case (20.0%/year) → the price is consistent with the projection.

That growth implies ~$8 bn of owner earnings in year 5 (vs ~$8 bn of our base case). It recalculates if the DCF assumptions are edited.

The model and the scenarios

Year-by-year model — REIT (equity)

A REIT is valued on price/Core-FFO (not P/E: the accounting depreciation of the property is not an economic cost). ⚠️ The real cash is AFFO (owner earnings), substantially lower than Core FFO —it subtracts recurring capex and non-cash straight-line rent—, and the dividend consumes almost all of the AFFO. It returns capital via dividend; it may issue equity to fund development. Total return adds the dividend collected along the way. In edit mode, the metric, shares, dividend, and exit multiple can be adjusted.

P/FFO exit: 3 years 19.0x · 5 years 18.0x

US$ bn / per share	TTM	+1a	+2a	+3a	+4a	+5a
Operation (editable: metric, shares)
FFO ($bn)	3.227	3.872	4.492	5.076	5.584	6.031
growth	—	+20%	+16%	+13%	+10%	+8%
Ocupación promedio, Seniors Housing Operating	87%	88%	89%	89%	90%	90%
FFO / acción	$4.44	$5.03	$5.56	$6.04	$6.45	$6.83
Shareholder return (dividend + buyback)
Dividend / share	2.96	3.11	3.27	3.43	3.6	3.78
Payout (div / metric)	67%	62%	59%	57%	56%	55%
Shares (M)	726.3	769.9	808.3	840.7	865.8	883.2
Multiples at today's price (equity, no EV) — how they compress
P/FFO (price / per share)	51.8x	45.8x	41.4x	38.1x	35.7x	33.7x
Value curve (per share × P/FFO exit multiple by year)
Value / share	—	$96	$106	$115	$119	$123
Total return vs price	—	(-57%)	(-31%)	(-19%)	(-13%)	(-10%)

Valuation · Base · 3 years at 19.0x · 5 years at 18.0x on FFO / acción

3 years

$115 -18.9%/year

per share 3y × P/FFO $6.04 × 19.0x

total return (with dividend) -18.9%/year

price appreciation only -20.7%/year

vs current price $244 value below

5 years

$123 -9.8%/year

per share 5y × P/FFO $6.83 × 18.0x

total return (with dividend) -9.8%/year

price appreciation only -11.8%/year

vs current price $244 value below

A REIT is valued on P/FFO (equity directly, without EV: accounting depreciation of property is not an economic cost). Rolling grid: year 0 is the TTM (FFO attributable to common shareholders, FY2025 $1.818bn, -22% versus FY24) normalized by adding back a one-off charge of $1,409M from the new Ten-Year Executive Continuity and Alignment Program recognized in the fourth quarter (total FY25 SBC $1,557M versus $75.8M in FY24 — a 20-fold jump, non-recurring and declared as such in the 10-K itself) — normalized FFO ~$3.227bn. Recent revenue growth (+40.2% FY25, +43.5% TTM) is mostly inorganic: large acquisitions in Seniors Housing Operating (Care UK Oct-2024, Barchester and HC-One Oct-2025) and a pending sale of ~$7.2bn of the Outpatient Medical portfolio. The path does not extrapolate that headline: it starts at segment-weighted organic growth (Same-Store NOI at Welltower's share: Seniors Housing Operating +21.0%, Triple-net +2.8%, Outpatient Medical +2.5%, ~17% weighted by revenue) plus the contribution of acquisitions already closed, decelerating toward a mature REIT pace. The share count keeps growing (it funds acquisitions with equity via the ATM program, ~9-17%/year in 2022-2025) but at a moderating pace. The exit multiple P/FFO 18× (base; bear 15× / bull 20×) compresses sharply from the level the market pays today on reported FFO (extreme unnormalized and still very high once normalized) — a seniors housing REIT with a demographic tailwind.

Today's multiple compresses on its own going forward as the metric per share grows. The exit multiple at 3 years is higher than the terminal at 5 years —at 3 years there is more growth still ahead—. Total return adds the dividend collected; the required return is applied to the base scenario.

Scenarios (bear / base / bull) — at 5 years

Bear Same-Store NOI stalls, the pace of acquisitions slows and share dilution moderates; normalized aggregate FFO +14% decelerating to +6% over five years; occupancy stalls at ~88% $86

Base Normalized aggregate FFO +20% decelerating to +8% over five years (weighted Same-Store NOI ~17% + already-closed acquisitions, funded with debt and share issuance); occupancy rises to ~90% $123

Bull Acceleration in Same-Store NOI + sustained pace of acquisitions + greater operating leverage from the Welltower Business System; normalized aggregate FFO +25% decelerating to +10% over five years; occupancy rises to ~92% $158

Value sensitivity

Value per share by growth scenario (rows) and the compression or expansion of the exit multiple (columns). The color shows whether it beats the required return.

Growth ↓ / Multiple →	Compression−15%	Base multiple	Expansion+15%
BearSame-Store NOI stalls · base ~15×/16× (5y/3y) P/FFO	$73 -17.7%	$86 -15.3%	$99 -13.1%
BaseNormalized aggregate FFO +20% decelerating to +8% over five years (weighted Same-Store NOI ~17% + already-closed acquisitions · base ~18×/19× (5y/3y) P/FFO	$105 -12.2%	$123 -9.5% · base case	$141 -7.2%
BullAcceleration in Same-Store NOI + sustained pace of acquisitions + greater operating leverage from the Welltower Business System; normalized aggregate FFO +25% decelerating to +10% over five years; occupancy rises to ~92% · base ~20×/21× P/FFO	$134 -8.1%	$158 -5.3%	$182 -2.7%

● exceeds 15% ● exceeds 10% ● falls short of 10%

Multiples — today

P/E 118.8x

EV / owner-FCF 54.0x

EV / EBIT 80.3x

EV / Sales 17.9x

FCF yield 1.9%

High today = growth is being paid for; they cheapen toward 3 and 5 years (see Projections).

Forward multiples

With today's price fixed and the metric growing, what multiple is being paid at 3 and 5 years. Today's high multiple is the price of growth: if the business grows, the entry multiple cheapens on its own.

Optionalities and margin of safety

Optionalities

They are valued separately, with their own rationale, and are not incorporated into the base or the verdict (they are excess return). When assigning them value — in Editmode —, the total with optionalities updates live, without moving the base.

Acquisition of the senior housing portfolio in the United Kingdom (~£5,200M, announced 2025)

The largest transaction announced by the company this year, not yet fully reflected in the projected path: it expands the international footprint (the United Kingdom already ~20.0% of revenue) and could accelerate FFO beyond the base case if executed and integrated as expected. It is valued separately due to execution and integration uncertainty.

Upside

Real estate loan portfolio (~$2,082M net, ~8.9% yield)

Generates an attractive interest return and functions as a pipeline for future direct property acquisitions; it is not the focus of the rental-FFO valuation and is treated as a marginal optionality, not a material separate cash flow.

Upside

Base value (multiples, at 5 years) $123

+ Optionalities (total) $0

= Value with optionalities $123

CAGR with optionalities -9.5%

The verdict, the base CAGR, and the margin of safety are always calculated on the base; optionalities do not alter them (with optionalities at $0 they do not move).

Maximum price to pay today — by required return

Each card fixes a required annual return and answers: if the business is worth $123 in 5 years, what is the maximum that can be paid today to obtain that return? Since it now trades at $230, the margin of safety is how much cheaper the market is than that maximum. The three thresholds: 4% covers inflation (the floor), 10% is the long-term average return, and 15% is the level of a great investment.

Return 4%

$119

maximum to pay today

No margin -94.2%

Return 10%

$91

maximum to pay today

No margin -152.5%

Return 15%

$74

maximum to pay today

No margin -210.4%

Return and margin of safety calculator

The maximum price to pay today to earn the required return, with the dividend collected as a separate flow. Both controls are editable.

Target price (in 5 years, ex-dividend) $123

method's base case: $123 · + dividends collected over 5 years $20 → total value to the shareholder $143

Required return 4.5%

risk-free rate (the method's floor): 4.5%

Maximum price

$116

Margin of safety

-98.6%

CAGR at market

-9.5%

With a target price of $123 in 5 years plus $20 of dividends collected (the dividend adds to the return, not to the price) and a required return of 4.5% annually, the maximum to pay today is $116. Against the current market price ($230), the margin of safety is -98.6% (trades above the maximum → a premium is paid) and the total return at that price would be -9.5% annually.

Synthesis

Valuation quality

Multiple vs the reference range. An extreme multiple on reported FFO (the correct figure) or 52× excluding the one-time stock-based compensation charge —a reading not taken as a valid normalization— against a reference range of 15-20× for a REIT — far above under either reading.
Growth vs multiple. The multiple compresses from today's extreme levels to 18× (base) by year 5, as growth converges from today's inorganic rate to sustainable organic growth (~17%→8%).
Margin of safety. Base -12%/year price (-10% with dividend); no visible discount to today's value.

ROIC vs the 10% bar — the compounding engine

3.6%

5.4%

ROIC

on invested capital

CFROIC

backed by cash

value created (above the bar) up to the bar 10% bar (opportunity cost)

The quality bar — return bands

The return on capital is judged against absolute bands; the value-creation floor is the market's opportunity cost (~10%). A stock's volatility does not measure business risk.

Exceptional ≥20%

Excellent 15-20%

Good 10-15%

Below the bar <10%

ROIC 4% → below the 10% bar. The bar is a measure of business quality, not the method's discount rate: value is discounted to today at the risk-free rate, and protection is required separately, as a margin of safety.

Owner earnings — the waterfall

EBIT

$2.1 bn

− Taxes

-$0 bn

+ D&A

+$2.1 bn

− Maint. capex

-$1 bn

− Δ WC

+$0 bn

Owner earnings

$3.1 bn

It charges maintenance capex (which EBITDA does not deduct). The growth capex ($13.9 bn) is voluntary and is not charged to the base — it depresses FCF today, creates value tomorrow.

Cash & reinvestment

FCF yield (owner-FCF / market value) 1.9%

Cash conversion (FCF / earnings) 220%

Reinvestment rate (growth capex / NOPAT) 674%

Intrinsic growth (g = reinv × ROIC) 24%

Capex / D&A 7.2x

Economic profit (CFROIC − WACC) -4.6 pp

Margins — trajectory

Each margin over sales, year by year: historical (solid line) → projection (dotted).

Net15%

Owner earnings — the detail

EBIT $2.1 bn

NOPAT (rate 1%) $2.1 bn

+ D&A $2.1 bn

− Maintenance capex $1.1 bn

− Δ working capital $0 bn

= Owner earnings $3.1 bn

Business quality

✕ ROIC exceeds the cost of capital (~10%)
✓ CFROIC backs up the ROIC (150%, cash vs. accruals)
✓ Healthy balance sheet (low corporate debt)
✓ Durable competitive moat (multiple advantages)

Quality — cash · ROIC · reinvestment

Cash quality (real cost of stock-based compensation). Reported FY2025 FFO carried a real, one-time stock-based compensation cost ($1,409M, 77% of reported FFO) — a cost the method always expenses; it is not treated as an artifact to be excluded.
Value creation (occupancy + NOI). Same-Store NOI in the operated segment +21.0% in 2025 confirms a real operational improvement, backed by Adjusted EBITDA (+32%) beyond the depressed accounting FFO.

Revenue trajectory

· $4.8

+27% $6

+40% $8.5

+43% $9.4

+14% $10.6

+14% $12.1

+14% $13.7

+7% $14.7

+7% $15.7

FY23

FY24

FY25

TTM

+1A

+2A

+3A

+4A

+5A

Historical CAGR +25% Projected 5y +11% Owner-FCF 5y —

Values in US$ bn. The % over each bar is the year-over-year (YoY) growth — each year, historical and projected, vs the prior one (the TTM vs the TTM from a year ago). The path comes from the same source as the table; years without their own series in the model are interpolated between the anchors. Historical solid, projection in a lighter shade.

Where the growth comes from · by segment

Weight in revenue and year-over-year (YoY) growth, in reported USD.

Segment · weight in the mix YoY growth

Seniors Housing Operating (operated senior housing) +41%

81% of the mix

Triple-net (net lease) +52%

11% of the mix

Outpatient Medical (outpatient medical buildings, being divested) -3%

8% of the mix

Reported growth by segment is inflated by acquisitions (Care UK, Barchester, HC-One in Seniors Housing Operating) and by conversions of Triple-net properties to the RIDEA structure — it is not organic. The real organic engine, measured by Same-Store NOI at Welltower's share, is much more modest: Seniors Housing Operating +21.0%, Triple-net +2.8%, Outpatient Medical +2.5% (~17% weighted by revenue). Outpatient Medical is also shrinking due to the ongoing ~$7.2bn sale of the portfolio.

Growth engine — operating drivers

Annual levels from the official filing (10-K); the % over each bar is the year-over-year (YoY) growth vs the prior year.

Average occupancy, Seniors Housing Operating (%)

· 85,6%

+2% 86,9%

+1% 87,4%

FY23

FY24

FY25

The driver of the Seniors Housing Operating segment is occupancy (rising strongly post-pandemic) combined with rate growth; for Triple-net it is contractual rent escalators (59 leases, weighted average +3.58% per year); for Outpatient Medical it is rent from medical buildings tied to hospital systems, currently shrinking due to the portfolio sale. Recent consolidated growth combines this organic driver with large acquisitions (Care UK, Barchester, HC-One) that cannot be extrapolated without limit.

Projections

Metric	FY23	FY24	FY25	TTM	+1A	+2A	+3a	+4A	+5a
Revenue	$4.8 bn	$6 bn (+27%)	$8.5 bn (+40%)	$9.4 bn (+43%)	$10.6 bn (+14%)	$12.1 bn (+14%)	$13.7 bn (+14%)	$14.7 bn (+7%)	$15.7 bn (+7%)
FFO (attributable to common stockholders)	—	$2.3 bn	$1.8 bn (-22%)	$3.2 bn	$3.8 bn (+16%)	$4.4 bn (+16%)	$5.1 bn (+16%)	$5.5 bn (+9%)	$6 bn (+9%)
Adjusted EBITDA	—	$2.4 bn	$3.2 bn (+32%)	$4.2 bn	$4.7 bn (+13%)	$5.3 bn (+13%)	$6 bn (+13%)	$6.7 bn (+11%)	$7.4 bn (+11%)
Net income (attrib., GAAP)	$0.3 bn	$1 bn (+180%)	$0.9 bn (-2%)	$1.4 bn	$1.3 bn (-7%)	$1.2 bn (-7%)	$1.2 bn (-7%)	$1.3 bn (+16%)	$1.6 bn (+16%)

The % are the annual (year-over-year) growth: each year —historical and projected— vs the prior one; the TTM (trailing 12m) vs the TTM of a year ago, to avoid overlapping windows. The historicals are exact figures from the official filings; the projected years come from the year-by-year model (the intermediate years without their own series are interpolated between the anchors). The projected columns (+1y…+5y) are 12-month windows counted from the TTM close (31-mar-2026): the projection starts from the most recently reported data, not the fiscal year. The projected base is realistic and unbiased — the risk discount is applied at the end, via the required return. The rationale for each metric is in the (i).

Growth quality

Real, not nominal. Organic growth (Same-Store NOI, occupancy) is real; the reported consolidated growth, by contrast, is mostly inorganic (acquisitions) and should not be extrapolated without adjustment.
Growth driver. Recovering occupancy (85.1%→87.4% in 2025) + contractual rent escalators + acquisitions funded with debt/equity. The weighted organic engine is ~17%.
Sustainability. The occupancy recovery has a natural ceiling (it cannot keep rising indefinitely); as it approaches pre-pandemic levels, organic growth converges toward inflation + development.

Moat strength

Width

None

Narrow

Wide

Trend

→ Stable

Sources of the moat

Network effect

partial — State licenses and certificate-of-need laws limit the number of authorized operators/properties in many states — a real regulatory barrier, though not a proprietary network effect.

Cost advantage

strong — The Welltower Business System standardizes data and operating practices across the operator network, generating efficiencies that a standalone operator or a smaller-scale REIT cannot replicate.

Intangibles / brand

strong — Proprietary data science platform —statistical and predictive models led by a team with doctoral training— used as a mandatory underwriting step for practically every senior housing investment.

Switching costs

strong — 96.9% of the triple-net properties are under master leases that group multiple properties per tenant: only the best cannot be selectively renewed or purchased, protecting Welltower against stress at an operator.

Efficient scale

strong — The largest senior housing REIT in the world (>2,500 properties, 712 direct employees), with a network of 62 operating partners that gives negotiating power and counterparty diversification.

The business and its moat

What it does and how it makes money

Welltower earns money in three ways, all within the same healthcare/senior housing real estate business. In Seniors Housing Operating (~78% of revenue, the fastest-growing portion) it directly captures the operating revenue and costs of the properties via RIDEA structures, sharing the result with 62 operating partners under incentive-based management contracts — Care UK, Cogir and Sunrise Senior Living account for 14%, 12% and 10% of the segment. In Triple-net (~11%) it collects long-term contractual rent (10 to 20 years, with escalators) under master leases that group multiple properties per tenant: 96.9% of these properties are under that structure, which protects Welltower if a tenant runs into trouble. In Outpatient Medical (~7%, declining) it leases outpatient medical buildings to healthcare providers, mostly affiliated with hospital systems; the company sold a ~$7.2bn portfolio of this segment in 2025.

It complements the portfolio with real estate loans (~$2,082M net, ~8.9% yield) and development/construction (~$739M in progress). The business is not valued on a P/E basis: accounting depreciation of the real estate does not reflect the real economics (the assets tend to appreciate), which is why the metric is FFO (Funds From Operations).

Scale and competitive position

Welltower operates a portfolio of more than 2,500 senior housing and wellness properties with only 712 direct employees — the real operating scale rests with the network of 62 operating partners. It is among the largest-capitalization REITs in the healthcare/senior housing sector of the S&P 500. The company anchors its capital allocation on a proprietary data science platform (led by a team with doctoral training) that produces predictive analytics —financial projections, occupancy trends, supply and demand dynamics— as a mandatory initial step of the underwriting process for practically every senior housing investment, plus the Welltower Business System, which standardizes data and operating practices across the operator network.

Competition for acquisitions is intense (other REITs, private equity funds, insurers, sovereign wealth funds) and is based on relationships and execution certainty, not just price; limited development during the pandemic continues to depress available new supply, pushing acquisition prices upward.

The moat: why it is hard to compete

Welltower's moat rests on five concrete sources. Its proprietary data science platform is a mandatory underwriting step that is difficult to replicate without the data scale of more than 2,500 properties. The network of 62 operating partners (with moderate concentration — the top three account for only 36% of the operated segment) gives it negotiating power and counterparty diversification. The master lease structure across 96.9% of the triple-net properties prevents a tenant from selectively renewing or buying only the best properties, protecting Welltower against stress at an operator. The Welltower Business System centralizes data and best practices at scale. And state licenses and certificate-of-need laws (which limit how many operators/properties are authorized in many states) are a real regulatory barrier to new supply.

Moat direction and threats

The physical-asset moat (licensed locations, scale, operator network) is wide and stable: recovering occupancy (85.1%→87.4% in 2025) and Same-Store NOI in the operated segment (+21.0%) show real demand, not just purchased growth, but that is the recovery of the occupancy cycle, not a unit-economics gap opening against competitors. The structural risks are clear: under RIDEA structures, Welltower —through its taxable subsidiary— is the legal party of record even though the operator controls clinical decisions, exposing it to compliance risks it does not directly control; operators' financial health depends on occupancy, private rates and Medicare/Medicaid reimbursement, and the 2025 'One Big Beautiful Bill Act' will cut Medicaid reimbursement rates by 10 percentage points per year starting in 2028. The year's largest acquisition (~£5,200M in the United Kingdom) increases currency and international regulatory exposure. These risks are not short-term noise: they are the reason organic growth —not the acquisition-driven headline— is the correct basis for the valuation.

Business / sector quality

Relevant in 10 years (recurrence). Demand for senior housing is structural (demographics, the silver economy); high recurrence and predictability of contractual rent.
Pricing power. Contractual rent escalators (59 leases, average +3.58%/year) in triple-net; in the operated segment, pricing power depends on occupancy and private rates, which are more variable.
Moat and its direction. Wide moat (proprietary data + scale + master leases + regulatory barriers), stable: the occupancy improvement is cycle recovery, not the direction of the moat. Counterweight: regulatory dependence on Medicaid reimbursement.
Cyclicality / sensitivity. Sensitive to rates (like any REIT) and to the financial health of operators/tenants; the post-pandemic occupancy recovery has already covered much of the ground.

Solvency margin

Each pillar between danger and solid — the further right, the more room.

Leverage (net debt / EBITDA) Net cash $0 bn

danger > 3× net cash

Interest coverage (EBIT / int.) 3.0x

tight < 1.7× solid > 3.5×

Reading for a REIT: it runs high leverage (LTV ~30-40%, ~5-6× debt/EBITDA) backed by income-producing real estate and an investment-grade rating — it is not judged by an industrial company's thresholds. EBIT/interest coverage is thin by design; EBITDA/interest coverage is higher.

Net cash position

$0 bn net cash (surplus)

Gross debt $17.9 bn

vs EBITDA cash 0.0x

In a REIT, debt is backed by income-producing real estate (LTV ~30-40%) and an investment-grade rating — it is low-cost funding for a real asset, not a vulnerability. High leverage is structural and healthy.

Debt composition

Not all debt is equal: only the structural needs refinancing; the rest is operational (self-liquidating).

$17.9 bn (100%)

Financial debt · structural — to be refinanced

Structural $17.9 bn (100% of total)vs net cash $0 bn → covered

Structural debt is what is exposed to the contraction phase of the cycle; operational debt (leases, matched funding) self-liquidates with the business.

Company health / solvency

✕Portfolio quality (occupancy + same-store NOI)Occupancy 87.4% · same-store NOI +17.0%
✕Dividend coverage (payout over AFFO)370% of AFFO

A traffic-light interpreted by the method (not generic): float (negative WC) adds up, capex is judged by incremental ROIC (malinvestment test), and a lender is not subjected to corporate solvency. The (i) shows the derivation of each number.

Health — balance sheet risks

Leverage. Long-term debt ~$17.9bn against equity ~$43.8bn (invested capital ~$57.0bn) — moderate for a REIT, funded with a mix of debt and equity.
Quality of reported FFO. Reported FFO carried a real executive compensation cost and the ongoing Outpatient Medical disposition; the year-0 used in this analysis's path, which excludes that one-time charge, is ~1.8× the reported figure — a material difference reflecting a large, non-recurring compensation event, not an adjustment that reduces the real cost already paid.
Dilution from financing. Diluted shares grew ~56% over three years (465M→726M) funding acquisitions — real and sustained, not a one-time event.

Who runs it

Shankh Mitra Public market reference; not confirmed against the 10-K or the DEF 14A proxy in the sections extracted by this pipeline (the 'Executive Officers' listing and the signature pages were not part of the material read) — verify against the primary filing before citing it as a source.

Skin in the game

Direct holdings of directors and executives as a group (13 people) of 2,577,936 shares —approximately 0.4% of diluted capital—, per the DEF 14A proxy: there is no controlling founder shareholder. Ownership is dominated by passive institutional managers (Vanguard ~12%, BlackRock ~9%, Capital Group ~5%, State Street ~5%, ~29% combined).

UPREIT structure: Welltower Inc. controls ~98.4% of Welltower OP, the operating partnership through which substantially all of the business is conducted.
Diluted shares grew from 465M (FY22) to 726M (TTM) — an increase of ~56% over three years, funding large acquisitions with equity issuance via the ATM program.

Capital allocation — indicators

Owner-FCF (shareholder's own cash) $3.1 bn

Reinvested / Dividends / Buybacks 55% / 30% / 0%

Dividend yield (today) 1.5%

Cash conversion (FCF / earnings) 220%

Shares — ownership and dilution

Who owns the shares — the alignment and whether there is a controlling shareholder.

12.0%

9.0%

69.6%

The Vanguard Group 12.0%

BlackRock 9.0%

Capital Group 5.0%

State Street 5.0%

Directors and executives (group) 0.4%

Remainder (institutional and retail float) 69.6%

Dilution

Net share dilution (YoY) +11.1%

SBC / market value (dilution rate) 0.9%

Dilution transfers value from the shareholder to the employee each year — watch that it does not erode value per share.

Management / capital allocation

Skin in the game. Low direct holdings of directors and executives (~0.4%, DEF 14A proxy); no controlling founder shareholder. Ownership dominated by passive institutional managers.
Capital allocation. Funds large acquisitions with debt and equity issuance (shares +47% over three years), not buybacks. The ten-year executive compensation charge is a point to watch regarding earnings quality.
Integrity / candor. The 10-K explicitly discloses the one-time stock-based compensation charge and its origin (the new executive continuity program) — transparent disclosure, though the cost is real and this analysis treats it as such, not as an event to be excluded from distributable cash.

Why it is not cheap

It is not cheap: it trades at an extreme entry multiple on reported FFO (the correct figure, because stock-based compensation is always expensed) and of 52× if the one-time compensation charge is excluded —a reading this analysis does not treat as a legitimate normalization—, in either case far above the method's reference range for a REIT (15-20×).
Reported FY2025 FFO carried a real, one-time $1,409M charge from the new ten-year executive compensation program — a cost the method always expenses, never excluded as if it were not real — and even looking at the business's recurring level without that charge, the price still implies a multiple far above the method's band.

No source of discount is identified (missing buyers or motivated sellers, §9): the price fully reflects —and probably more than reflects— the demographic tailwind and the occupancy recovery. This is the opposite case of an opportunity: a quality business priced for perfection, near its all-time high, on top of reported FFO that is additionally depressed by a one-time accounting charge.

Return asymmetry — risk/reward

The annual return (CAGR at 5 years) in each scenario, with the total period return below — the margin of safety made visual: upside range wide, downside range narrow.

-15%/year

-56% total

Bear

bad scenario

-10%/year

-39% total

Base

realistic

-5%/year

-24% total

Bull

upside

Even in the bear scenario, the return holds at -15%/year (-56% total): the margin of safety protects the downside. The bull (-5%/year, -24% total) exceeds it comfortably — a favorable asymmetry, with a narrow downside range and a wide upside range.

Bear case — disconfirmation

Same-Store NOI in the operated segment (+21.0% in 2025) decelerates abruptly as the post-pandemic occupancy recovery runs out, and market consensus (which today pays a very high multiple) adjusts downward.
The ten-year executive compensation program keeps recognizing large charges in the following years, keeping reported FFO below the level used as this analysis's path year-0.
The Medicaid reimbursement cut (OBBBA, starting 2028) pressures operators' ability to pay, especially in the Triple-net segment.
Dilution from share issuance (funding acquisitions) continues at a pace similar to the historical rate (~9-17%/year) without FFO per share growing enough to offset it.

Bull case — the thesis for

Same-Store NOI in the operated segment sustains a +15-20% pace for several more years as demographics (the silver economy) drive structural demand for senior housing.
The acquisition of the United Kingdom portfolio (~£5,200M) integrates successfully and accelerates FFO above the base path, reinforcing international scale.
The executive compensation charge turns out to be mostly a single-quarter event (it does not recur at that level in subsequent years), and reported FFO converges quickly toward the level used as the path's year-0.
The data science platform and the Welltower Business System enable continued acquisition and stabilization of properties at a pace faster than competitors, sustaining double-digit FFO growth.

Risks — what breaks the base case

Medicaid reimbursement (OBBBA). The reimbursement rate cut starting in 2028 pressures operators' ability to pay, especially in Triple-net.
Recurrence of the compensation charge. The executive continuity program runs ten years; if it keeps recognizing large charges in future years, reported FFO stays below the level used as this analysis's path year-0.
Dependence on operators/tenants. The financial health of 62 operating partners and the triple-net tenants determines the ability to pay; a failure under a master lease exposes multiple properties at once.
International currency and regulatory exposure. The United Kingdom (~20.0% of revenue) and Canada (~6.8%), with the year's largest acquisition (~£5,200M) increasing that exposure.
Valuation with no margin. It trades at an entry multiple far above the method's reference range — little cushion against any disappointment.

The business

The valuation

The margin of safety

What to watch

What it does and how it makes money

Scale and competitive position

The moat: why it is hard to compete

Moat direction and threats

Other companies of the same type